胶质母细胞瘤细胞来源胞外囊泡DNA的全基因组甲基化谱可实现肿瘤分类
本研究从胶质母细胞瘤细胞分泌的胞外囊泡(EV)、匹配的培养细胞和肿瘤中分离DNA,用850k阵列进行甲基化与拷贝数谱分析,并用靶向基因面板测序检测突变。结果显示EV-DNA的全基因组甲基化谱正确识别了亲本细胞和原发肿瘤的甲基化类别,包括MGMT启动子甲基化状态,且肿瘤特异性突变和拷贝数变异可高精度检出。结论提供原理验证:EV-DNA反映胶质母细胞瘤细胞的全基因组甲基化、拷贝数变异和突变状态,并支持其分子分类。
要点
- EV-DNA可正确识别胶质母细胞瘤的甲基化类别及MGMT启动子甲基化状态。
- EV-DNA可高精度检出肿瘤特异性突变和拷贝数变异。
- 不同EV分离技术不影响甲基化谱和拷贝数变异结果。
核心结论
- EV-DNA反映胶质母细胞瘤细胞的全基因组甲基化、拷贝数变异和突变状态,并支持其分子分类。
研究设计与样本
- 从胶质母细胞瘤细胞分泌的EV、匹配培养细胞和肿瘤中分离DNA。
- 用850k阵列进行甲基化与拷贝数谱分析,用靶向基因面板测序检测突变。
- 用直接随机光学重建显微镜定位并定量EV-DNA,用质谱蛋白质组学差异定量蛋白。
主要发现
- EV-DNA的全基因组甲基化谱正确识别亲本细胞和原发肿瘤的甲基化类别,包括MGMT启动子甲基化状态。
- 肿瘤特异性突变和拷贝数变异在EV-DNA中被高精度检出。
- 不同EV分离技术不影响甲基化谱和拷贝数变异结果。
- DNA存在于EV内部和EV表面。
- 蛋白质组分析未能实现特异性肿瘤识别或分类,但识别出可能有助于从体液中富集肿瘤来源循环EV的肿瘤相关蛋白。
临床怎么用
- EV-DNA甲基化谱有望作为液体活检来源,用于胶质母细胞瘤的分子分类、患者分层和治疗监测。
局限性
- 本研究为原理验证,蛋白质组分析未实现特异性肿瘤识别或分类。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Genome-wide DNA methylation profiling has recently been developed into a tool that allows tumor classification in central nervous system tumors. Extracellular vesicles (EVs) are released by tumor cells and contain high molecular weight DNA, rendering EVs a potential biomarker source to identify tumor subgroups, stratify patients and monitor therapy by liquid biopsy. We investigated whether the DNA in glioblastoma cell-derived EVs reflects genome-wide tumor methylation and mutational profiles and allows noninvasive tumor subtype classification. METHODS: DNA was isolated from EVs secreted by glioblastoma cells as well as from matching cultured cells and tumors. EV-DNA was localized and quantified by direct stochastic optical reconstruction microscopy. Methylation and copy number profiling was performed using 850k arrays. Mutations were identified by targeted gene panel sequencing. Proteins were differentially quantified by mass spectrometric proteomics. RESULTS: Genome-wide methylation profiling of glioblastoma-derived EVs correctly identified the methylation class of the parental cells and original tumors, including the MGMT promoter methylation status. Tumor-specific mutations and copy number variations (CNV) were detected in EV-DNA with high accuracy. Different EV isolation techniques did not affect the methylation profiling and CNV results. DNA was present inside EVs and on the EV surface. Proteome analysis did not allow specific tumor identification or classification but identified tumor-associated proteins that could potentially be useful for enriching tumor-derived circulating EVs from biofluids. CONCLUSIONS: This study provides proof of principle that EV-DNA reflects the genome-wide methylation, CNV, and mutational status of glioblastoma cells and enables their molecular classification.
引用
- Maire CL, Fuh MM, Kaulich K, et al. Genome-wide methylation profiling of glioblastoma cell-derived extracellular vesicle DNA allows tumor classification. Neuro Oncol. 2021. PMID: 33508126. doi:10.1093/neuonc/noab012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。